Update on Neuropathic Pain Treatment: Ion Channel Blockers and Gabapentinoids

被引：11

作者：

Chen, Lucy ^{[1
]}

Mao, Jianren ^{[1
]}

机构：

[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA

来源：

CURRENT PAIN AND HEADACHE REPORTS | 2013年 / 17卷 / 09期

关键词：

Ion channel blockers; Gabapentinoids; Neuropathic pain; Chronic pain; Sodium channel blockers; LIDOCAINE PATCH 5-PERCENT; DIABETIC PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; DOUBLE-BLIND; OXCARBAZEPINE MONOTHERAPY; SYMPTOMATIC TREATMENT; TRIGEMINAL NEURALGIA; ANTIEPILEPTIC DRUGS; CLINICAL-EFFICACY; SENSORY NEURONS;

D O I：

10.1007/s11916-013-0359-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Neuropathic pain is a debilitating chronic pain condition, which remains difficult to treat. The current main-stays of treatment include physical therapy, interventional procedures and medications. Among medications, ion channel blockers and gabapentinoids are the 2 classes of drugs commonly used to treat neuropathic pain. It has been suggested that these medications may be useful to treat a variety of neuropathic pain conditions. This article provides several updates on the utility of both ion channel blockers and gabapentinoids for the treatment of neuropathic pain.

引用

收藏

页数：8

相关论文

共 104 条

[1]

Achar A, 2012, ACTA DERMATOVENER CR, V20, P89

[2] Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale [J].

Argoff, CE ;

Galer, BS ;

Jensen, MP ;

Oleka, N ;

Gammaitoni, AR .

CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 :S21-S28

[3] Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview [J].

Argoff, Charles E. ;

Chen, Cuiping ;

Cowles, Verne E. .

EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (09) :1147-1160

[4] Cross-Over, Open-Label Trial of the Effects of Gabapentin versus Pregabalin on Painful Peripheral Neuropathy and Health-Related Quality of Life in Haemodialysis Patients [J].

Atalay, Huseyin ;

Solak, Yalcin ;

Biyik, Zeynep ;

Gaipov, Abduzhappar ;

Guney, Figen ;

Turk, Suleyman .

CLINICAL DRUG INVESTIGATION, 2013, 33 (06) :401-408

[5] Zonisamide in the treatment of painful diabetic neuropathy: A randomized, double-blind, placebo-controlled pilot study [J].

Atli, A ;

Dogra, S .

PAIN MEDICINE, 2005, 6 (03) :225-234

[6] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].

Backonja, M ;

Beydoun, A ;

Edwards, KR ;

Schwartz, SL ;

Fonseca, V ;

Hes, M ;

LaMoreaux, L ;

Garofalo, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836

[7] Neuropathic Pain Therapy: From Bench to Bedside [J].

Backonja, Miroslav 'Misha' .

SEMINARS IN NEUROLOGY, 2012, 32 (03) :264-268

[8] Gabapentin monotherapy for the symptomatic treatment of painful neuropathy: A multicenter, double-blind, placebo-controlled trial in patients with diabetes mellitus [J].

Backonja, MM .

EPILEPSIA, 1999, 40 :S57-S59

[9] Gabapentin for once-daily treatment of post-herpetic neuralgia: a review [J].

Beal, Benjamin ;

Moeller-Bertram, Tobias ;

Schilling, Jan M. ;

Wallace, Mark S. .

CLINICAL INTERVENTIONS IN AGING, 2012, 7 :249-255

[10] Future directions in the management of pain by intraspinal drug delivery [J].

Bennett, G ;

Deer, T ;

Du Pen, S ;

Rauck, R ;

Yaksh, T ;

Hassenbusch, SJ .

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 20 (02) :S44-S50

← 1 2 3 4 5 6 7 8 9 10 →